Current and future trends in the multidisciplinary approach for high-risk breast cancer. The experience of the Milan Cancer Institute

被引：19
作者：
Bonadonna, G
机构：
[1] Division of Medical Oncology, Department of Cancer Medicine, Istituto Nazionale Tumori, Milan
来源：
EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 02期
关键词：
D O I：
10.1016/0959-8049(95)00612-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：209 / 214
页数：6
相关论文
共 32 条
[1]  
AAPRO MS, 1995, SEMIN ONCOL, V22, P1
[2]  
ABELOFF MD, 1995, SEMIN ONCOL, V22, P1
[3]  
[Anonymous], 1992, Lancet
[4]   PRIMARY CHEMOTHERAPY TO AVOID MASTECTOMY IN TUMORS WITH DIAMETERS OF 3 CENTIMETERS OR MORE [J].
BONADONNA, G ;
VERONESI, U ;
BRAMBILLA, C ;
FERRARI, L ;
LUINI, A ;
GRECO, M ;
BARTOLI, C ;
DEYOLDI, GC ;
ZUCALI, R ;
RILKE, F ;
ANDREOLA, S ;
SILVESTRINI, R ;
DIFRONZO, G ;
VALAGUSSA, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (19) :1539-1545
[5]  
BONADONNA G, 1992, CANCER RES, V52, P2127
[6]  
Bonadonna G, 1995, Surg Oncol Clin N Am, V4, P701
[7]   CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP [J].
BONADONNA, G ;
VALAGUSSA, P ;
MOLITERNI, A ;
ZAMBETTI, M ;
BRAMBILLA, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :901-906
[8]   PRIMARY CHEMOTHERAPY IN SURGICALLY RESECTABLE BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P ;
ZUCALI, R ;
SALVADORI, B .
CA-A CANCER JOURNAL FOR CLINICIANS, 1995, 45 (04) :227-243
[9]  
BONADONNA G, IN PRESS SEMIN ONCOL
[10]  
Bonadonna Gianni, 1995, JAMA (Journal of the American Medical Association), V273, P542, DOI 10.1001/jama.273.7.542
1234